Farrukh T Awan Selected Research

ibrutinib

10/2023	Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review.
1/2023	Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity.
1/2022	Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
1/2022	Cardiotoxicity of BTK inhibitors: ibrutinib and beyond.
1/2022	International consensus statement on the management of cardiovascular risk of Bruton's tyrosine kinase inhibitors in CLL.
1/2021	Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia.
12/2020	Cardio-Oncology: A Win-Win Situation: How Solving the Mystery of an Ibrutinib Off-Target Effect Reveals New Insights Into Atrial Fibrillation Mechanisms.
11/2020	Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia.
12/2019	Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib.
11/2019	Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Farrukh T Awan Research Topics

Disease

32	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 01/2009
18	Neoplasms (Cancer) 10/2023 - 06/2007
8	Lymphoma (Lymphomas) 01/2023 - 01/2010
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2021 - 01/2012
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 10/2008
5	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 10/2018
5	Atrial Fibrillation 10/2023 - 09/2017
5	Hematologic Neoplasms (Hematological Malignancy) 04/2023 - 06/2016
3	Hypertension (High Blood Pressure) 01/2023 - 01/2022
3	Infections 10/2022 - 03/2017
3	Tumor Lysis Syndrome 10/2020 - 06/2016
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 01/2015
3	Thrombocytopenia (Thrombopenia) 03/2017 - 12/2013
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 05/2008
2	Heart Failure 01/2023 - 01/2022
2	Cardiotoxicity 01/2023 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2022
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 04/2008
2	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2019
2	Hemorrhage 01/2021 - 09/2017
2	Systemic Mastocytosis 01/2020 - 06/2016
2	Headache (Headaches) 01/2019 - 01/2018
2	Disease Progression 01/2018 - 01/2016
2	Neutropenia 03/2017 - 01/2015
2	Nausea 01/2015 - 06/2007
2	Multiple Myeloma 01/2012 - 01/2010
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2023
1	Ascorbic Acid Deficiency (Vitamin C Deficiency) 01/2023
1	Sudden Death 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	COVID-19 10/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2022
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Ischemic Stroke 01/2021
1	Abnormal Karyotype 12/2020
1	Lymphocytosis 01/2020
1	Thrombosis (Thrombus) 11/2019
1	Opportunistic Infections (Opportunistic Infection) 10/2019
1	Cough 01/2019
1	Diarrhea 01/2019
1	Stroke (Strokes) 09/2017
1	Sepsis (Septicemia) 03/2017

Drug/Important Bio-Agent (IBA)

19	ibrutinibIBA 10/2023 - 01/2016
11	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023 - 01/2016
6	acalabrutinibIBA 10/2022 - 01/2016
5	Rituximab (Mabthera)FDA Link 01/2023 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 12/2020 - 02/2014
3	Chimeric Antigen ReceptorsIBA 11/2023 - 12/2019
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2023 - 07/2021
3	Lenalidomide (CC 5013)FDA Link 12/2020 - 01/2010
3	obinutuzumabIBA 11/2020 - 04/2014
3	venetoclaxIBA 11/2020 - 10/2018
3	Monoclonal AntibodiesIBA 10/2018 - 02/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
2	fludarabineIBA 01/2020 - 01/2009
2	midostaurinIBA 01/2020 - 06/2016
2	TRU 016IBA 01/2015 - 02/2014
2	Chlorambucil (Leukeran)FDA Link 04/2014 - 01/2009
1	Carmustine (FIVB)FDA Link 11/2023
1	COVID-19 VaccinesIBA 04/2023
1	VaccinesIBA 04/2023
1	Immunoglobulin G (IgG)IBA 04/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	GadoliniumIBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	ChemokinesIBA 01/2021
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 01/2021
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 12/2020
1	Immunoglobulin Variable RegionIBA 01/2020
1	tisagenlecleucelIBA 12/2019
1	axicabtagene ciloleucelIBA 12/2019
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 01/2019
1	Syk KinaseIBA 01/2019
1	AnthracyclinesIBA 01/2018
1	coltuximab ravtansineIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2017
1	ofatumumab FDA Link 03/2017
1	idelalisibIBA 03/2017

Therapy/Procedure

30	Therapeutics 11/2023 - 01/2010
8	Cell Transplantation 01/2023 - 01/2012
6	Drug Therapy (Chemotherapy) 10/2023 - 06/2007
4	Homologous Transplantation 04/2021 - 04/2008
3	Transplantation 01/2023 - 12/2016
3	Salvage Therapy 01/2023 - 01/2016
3	Hematopoietic Stem Cell Transplantation 10/2008 - 04/2008
2	Aftercare (After-Treatment) 01/2023 - 01/2009
2	Immunotherapy 12/2019 - 01/2018
1	Radiotherapy 03/2023
1	Autologous Transplantation 02/2022
1	MDC protocol 01/2022
1	Thrombolytic Therapy 01/2021